Cargando…
Commentary on “Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes”
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106250/ https://www.ncbi.nlm.nih.gov/pubmed/36914942 http://dx.doi.org/10.1097/CM9.0000000000002594 |
_version_ | 1785026389840232448 |
---|---|
author | Lin, Zhemin Niu, Yinong |
author_facet | Lin, Zhemin Niu, Yinong |
author_sort | Lin, Zhemin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10106250 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-101062502023-04-17 Commentary on “Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes” Lin, Zhemin Niu, Yinong Chin Med J (Engl) Commentary Lippincott Williams & Wilkins 2023-03-05 2023-03-13 /pmc/articles/PMC10106250/ /pubmed/36914942 http://dx.doi.org/10.1097/CM9.0000000000002594 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Commentary Lin, Zhemin Niu, Yinong Commentary on “Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes” |
title | Commentary on “Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes” |
title_full | Commentary on “Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes” |
title_fullStr | Commentary on “Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes” |
title_full_unstemmed | Commentary on “Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes” |
title_short | Commentary on “Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes” |
title_sort | commentary on “integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes” |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106250/ https://www.ncbi.nlm.nih.gov/pubmed/36914942 http://dx.doi.org/10.1097/CM9.0000000000002594 |
work_keys_str_mv | AT linzhemin commentaryonintegrativemultiplatformmolecularprofilingofbenignprostatichyperplasiaidentifiesdistinctsubtypes AT niuyinong commentaryonintegrativemultiplatformmolecularprofilingofbenignprostatichyperplasiaidentifiesdistinctsubtypes |